AZ’ COPD therapy wins US approval
Breztri Aerosphere is also under regulatory review in the EU
Read More
Tag: Breztri Aerosphere
Breztri Aerosphere cut rate of COPD exacerbations in PhIII trial
The triple therapy is currently under review for COPD in both the EU and US
Read More
AZ’ triple combo hits endpoint in COPD trial
Breztri Aerosphere – formerly known as PT010 – showed a 52% reduction in exacerbations.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
